Tumor Lysis Syndrome: New Challenges and Recent Advances
Open Access
- 1 January 2014
- journal article
- review article
- Published by Elsevier in Advances in Chronic Kidney Disease
- Vol. 21 (1) , 18-26
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- The Tumor Lysis SyndromeNew England Journal of Medicine, 2011
- Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III StudyJournal of Clinical Oncology, 2010
- Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and ManagementAmerican Journal of Kidney Diseases, 2010
- Disorders Involving Calcium, Phosphorus, and MagnesiumPrimary Care: Clinics in Office Practice, 2008
- Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicaseEuropean Journal of Haematology, 2007
- Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndromeCancer, 2007
- Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemiaBone Marrow Transplantation, 2006
- A predictive model for the detection of tumor lysis syndrome during AML induction therapyLeukemia & Lymphoma, 2006
- A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapyLeukemia Research, 2005
- Tumour lysis syndrome: new therapeutic strategies and classificationBritish Journal of Haematology, 2004